* Seeks injunction against distributing generic Allegra-D
* Files motion along with Sanofi-Aventis US unit
* Albany shares fall 1 pct
March 23 Albany Molecular Research Inc (AMRI.O)
along with Sanofi Aventis SA's (SASY.PA) U.S. unit sought a
preliminary injunction against India's Dr Reddy's Laboratories
Ltd (REDY.BO) from distributing a copycat version of allergy
The companies motion, filed in a federal court in New
Jersey, comes as a response to the U.S. health regulators'
approval of Dr Reddy's generic version on March 17.
In September last year, Albany Molecular, which provides
drug discovery, development and manufacturing services, had
sued the Indian generic drugmaker alleging infringement of
patents related to the manufacturing process of the drug.
Sanofi-Aventis holds the patents on the drug.
Shares of Albany Molecular were down 1 percent at $8.87 in
midday trade Tuesday on Nasdaq, while American Depositary
Shares of Dr Reddy's were up 2.5 percent at $29.00 on the New
York Stock Exchange.
(Reporting by Vidya L Nathan in Bangalore; Editing by